Sponsored content for Parexel by BioPharma Dive's Brand Studio
WEBINAR ON DEMAND
Duration: 1 hour
Cellular and gene therapies are expected to represent one of the greatest advances in medical treatments since the introduction of monoclonal antibodies.
Cellular therapies are having a significant impact on hematological malignancies, while gene therapy programs for rare and non-rare diseases could benefit some 2.4 billion patients worldwide.
Researchers anticipate an increase of gene therapy products that can address monogenic inherited diseases, such as those that involve metabolic disorder and neurological conditions – it’s an enormous opportunity.
This webinar addresses the complex path to developing and commercializing a cell and gene therapy product, common obstacles, strategies for patient recruitment and more. At the end of the webinar, participants will be able to:
Understand clinical potential for cell and gene therapies
Take steps to avoid barriers for trial delivery
Implement effective strategy for patient recruitment inclusive of pediatric populations
Structure protocols for minimal patient burden and maximal study procedure compliance
Matthew Cooney, M.D. Vice President, Global Medical Services Parexel
Roberta Steere Senior Solutions Consultant Director, Early Product Development, Oncology
Altair Silva Director – Integrated Solutions Patient Recruitment Strategy Group Parexel